Evidence map›Paper›PMID 35146362›Full record

ArticleLe infezioni in medicina2021

Development of post-COVID-19 cardiovascular events: an analysis of clinical features and risk factors from a single hospital retrospective study.

Gianluca Cuomo, Cinzia Puzzolante, Vittorio Iadisernia, Antonella Santoro, Marianna Menozzi, Federica Carli, Margherita Digaetano, Gabriella Orlando, Erica Franceschini, Andrea Bedini and 11 more

Open access · bronzeAbstract read
In one paragraph

Article in Le infezioni in medicina, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
0.5field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 2 institutions in 1 country.

Gianluca CuomoInfectious Diseases Clinic, Azienda Ospedaliero-Universitaria di Modena, Modena, Italy.
Cinzia PuzzolanteInfectious Diseases Clinic, Azienda Ospedaliero-Universitaria di Modena, Modena, Italy.
Vittorio IadiserniaInfectious Diseases Clinic, Azienda Ospedaliero-Universitaria di Modena, Modena, Italy.
Antonella SantoroInfectious Diseases Clinic, Azienda Ospedaliero-Universitaria di Modena, Modena, Italy.
Marianna MenozziInfectious Diseases Clinic, Azienda Ospedaliero-Universitaria di Modena, Modena, Italy.
Federica CarliInfectious Diseases Clinic, Azienda Ospedaliero-Universitaria di Modena, Modena, Italy.
Margherita DigaetanoInfectious Diseases Clinic, Azienda Ospedaliero-Universitaria di Modena, Modena, Italy.
Gabriella OrlandoInfectious Diseases Clinic, Azienda Ospedaliero-Universitaria di Modena, Modena, Italy.
Erica FranceschiniInfectious Diseases Clinic, Azienda Ospedaliero-Universitaria di Modena, Modena, Italy.
Andrea BediniInfectious Diseases Clinic, Azienda Ospedaliero-Universitaria di Modena, Modena, Italy.
Marianna MeschiariInfectious Diseases Clinic, Azienda Ospedaliero-Universitaria di Modena, Modena, Italy.
Lisa ManziniInfectious Diseases Clinic, Azienda Ospedaliero-Universitaria di Modena, Modena, Italy.
Luca CorradiInfectious Diseases Clinic, Azienda Ospedaliero-Universitaria di Modena, Modena, Italy.
Jovana MilicUniversity of Modena and Reggio Emilia, Italy.
Vanni BorghiUniversity of Modena and Reggio Emilia, Italy.
Lucio BrugioniInternal Medicine and Critical Area Unit, Azienda Ospedaliero-Universitaria di Modena, Modena, Italy.
Antonello PietrangeloUniversity of Modena and Reggio Emilia, Italy.
Enrico CliniUniversity of Modena and Reggio Emilia, Italy.
Massimo GirardisUniversity of Modena and Reggio Emilia, Italy.
Giovanni GuaraldiInfectious Diseases Clinic, Azienda Ospedaliero-Universitaria di Modena, Modena, Italy.
Cristina MussiniInfectious Diseases Clinic, Azienda Ospedaliero-Universitaria di Modena, Modena, Italy.
Policlinico di Modena · ITUniversity of Modena and Reggio Emilia · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cardiovascular complications after a SARS-CoV-2 infection are a phenomenon of relevant scientific interest. The aim of this study was to analyze the onset of post-COVID-19 cardiovascular events in patients hospitalized in a tertiary care center. This is a retrospective study conducted on patients hospitalized over a period of three months. The patients were older than 18 years of age and had a diagnosis of COVID-19 infection confirmed from a nasopharyngeal swab sample. Anamnestic and clinical-laboratory data were collected. Cardiovascular events at 30 days were defined as follows: arrhythmias, myocardial infarction, myocarditis, and pulmonary embolism. Univariate analysis (Student's t-test or Mann-Whitney U test, as appropriate) and multivariate analysis (multinomial logistic regression) were applied to the data. A total of 394 patients were included; they were mostly males and had a median age of 65.5 years. Previous cardiovascular disease was present in 14.7% of patients. Oxygen therapy was required for 77.9%, and 53% received anticoagulant therapy. The overall 30-day mortality was 20.3%. A cardiovascular event developed in 15.7% of the subjects. These were mainly pulmonary embolism (9.4%), followed by arrhythmias (3.3%), myocardial infarction (2.3%), and myocarditis (0.8%). Patients who developed cardiovascular events upon univariate analysis were significantly older, with major comorbidities, a more compromised respiratory situation, and a higher mortality rate. Multivariate analysis revealed independent factors that were significantly associated with the development of cardiovascular events: hypertension, endotracheal intubation, and age older than 75 years. In patients with COVID-19, the development of a cardiovascular event occurs quite frequently and is mainly seen in elderly subjects with comorbidities (especially hypertension) in the presence of a severe respiratory picture.

Indexed as

cardiovascular diseasesCOVID-19SARS-CoV-2

Identifiers

PMID35146362
PMCPMC8805477
OpenAlexW4200391977

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.